Tiapride
Atypical antipsychotic medication
Tiapride | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Tiapride is an atypical antipsychotic medication primarily used in the treatment of psychosis, dyskinesia, and alcohol withdrawal syndrome. It is known for its selective action on the dopamine D2 and D3 receptors, which contributes to its therapeutic effects.
Pharmacology
Tiapride is classified as a benzamide derivative and functions as a selective dopamine antagonist. Its primary mechanism of action involves blocking the dopamine D2 and D3 receptors, which are implicated in the regulation of mood and movement. This selective antagonism helps alleviate symptoms of psychosis and movement disorders without the extensive side effects associated with typical antipsychotics.
Clinical Uses
Tiapride is utilized in various clinical settings, including:
- Psychosis: It is effective in managing symptoms of psychosis, particularly in patients who are sensitive to the side effects of other antipsychotic medications.
- Dyskinesia: Tiapride is used to treat movement disorders such as tardive dyskinesia and Huntington's disease.
- Alcohol Withdrawal Syndrome: It helps in managing symptoms associated with alcohol withdrawal, providing a calming effect without significant sedation.
Side Effects
While tiapride is generally well-tolerated, it can cause some side effects, including:
Dosage and Administration
Tiapride is administered orally, and the dosage varies depending on the condition being treated. It is important to adjust the dosage based on the patient's response and tolerance to the medication.
Chemical Properties
Tiapride is a benzamide derivative with a chemical structure that allows it to selectively bind to dopamine receptors. Its molecular formula is C15H24N2O4S, and it has a molecular weight of 328.43 g/mol.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD